Florida-based wealth advisory J. L. Bainbridge disclosed a purchase of Eli Lilly and Company valued at approximately $45.6 ...

Eli Lilly's Mounjaro clocked in ₹80 crore in September, second only to India’s leading brand of the month, GSK’s Augmentin, ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

Hims & Hears Health (HIMS) broke its uptrend that began in August at around $42. The stock peaked at over $60, only to close ...

A real weight loss drug, called retatrutide, is currently being developed by pharmaceutical giant Eli Lilly, but there has ...

In case you have $5,000 that is not required to pay bills or for any other contingencies, then picking stakes in either of ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

Investing.com -- Novo Nordisk (NYSE:NVO) stock fell 3.5% and Eli Lilly (NYSE:LLY) shares dropped 3% in after-hours trading ...

Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...